CC
Casdin Capital Portfolio holdings
AUM $1.1B
1-Year Return
24.98%
This Quarter Return
+71.3%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$910M
AUM Growth
+$326M
(+56%)
Cap. Flow
+$44.1M
Cap. Flow
% of AUM
4.85%
Top 10 Holdings %
Top 10 Hldgs %
64.43%
Holding
33
New
2
Increased
10
Reduced
4
Closed
4
Top Buys
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$25.7M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$18.5M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
+$16.7M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
+$14M |
| 5 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$11.4M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$50.4M |
| 2 |
Agios Pharmaceuticals
AGIO
|
+$7.42M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$5.79M |
| 4 |
NVTA
Invitae Corporation
NVTA
|
+$4.68M |
| 5 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
+$3.19M |
Sector Composition
| 1 | Healthcare | 79.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCE
1
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $107M | 11.76% |
940,000
+100,000
| +12% | +$11.4M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $67.9M | 7.46% |
848,648
+208,648
| +33% | +$16.7M |
|
|
MYOK
3
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $66.8M | 7.34% |
1,285,000
+495,000
| +63% | +$25.7M |
|
|
SAGE
4
DELISTED
Sage Therapeutics
SAGE
| $63.6M | 6.99% |
400,000
+88,000
| +28% | +$14M |
|
|
BLUE
5
DELISTED
bluebird bio
BLUE
| $56.2M | 6.18% |
27,599
+2,123
| +8% | +$4.33M |
|
|
NVTA
6
DELISTED
Invitae Corporation
NVTA
| $51.5M | 5.66% |
2,200,000
-200,000
| -8% | -$4.68M |
|
7
Fate Therapeutics
FATE
$110M
| $44.8M | 4.92% |
2,550,000
| – | – |
|
8
Dianthus Therapeutics
DNTH
$1.49B
| $43.5M | 4.78% |
165,207
| – | – |
|
9
BioLife Solutions
BLFS
$1.24B
| $43.4M | 4.77% |
2,428,571
| – | – |
|
10
Alnylam Pharmaceuticals
ALNY
$60.5B
| $41.6M | 4.57% |
445,000
+90,000
| +25% | +$8.41M |
|
11
Codexis
CDXS
$225M
| $41.6M | 4.57% |
2,025,000
| – | – |
|
|
BOLD
12
DELISTED
Audentes Therapeutics, Inc
BOLD
| $39.4M | 4.33% |
1,010,000
+150,000
| +17% | +$5.85M |
|
|
13
Sarepta Therapeutics
SRPT
$1.89B
| $36.4M | 3.99% |
305,000
+155,000
| +103% | +$18.5M |
|
|
GNMK
14
DELISTED
GenMark Diagnostics, Inc
GNMK
| $23.9M | 2.62% |
3,365,000
-450,000
| -12% | -$3.19M |
|
|
15
Agios Pharmaceuticals
AGIO
$2.13B
| $22.6M | 2.48% |
335,000
-110,000
| -25% | -$7.42M |
|
16
Voyager Therapeutics
VYGR
$236M
| $21.6M | 2.37% |
1,128,075
| – | – |
|
|
CNST
17
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $21.1M | 2.32% |
1,556,999
+1
| +0% | +$14 |
|
18
Illumina
ILMN
$15.6B
| $18.6M | 2.05% |
61,680
| – | – |
|
|
GBT
19
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $15.9M | 1.74% |
300,000
-50,000
| -14% | -$2.65M |
|
|
GRTS
20
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $14.9M | 1.64% |
1,120,586
+400,000
| +56% | +$5.32M |
|
21
Editas Medicine
EDIT
$254M
| $11.7M | 1.29% |
480,000
| – | – |
|
22
Sangamo Therapeutics
SGMO
$155M
| $10.3M | 1.13% |
1,080,000
| – | – |
|
23
Q32 Bio
QTTB
$22.9M
| $9.71M | 1.07% |
19,444
| – | – |
|
|
ONC
24
BeOne Medicines Ltd. American Depositary Shares
ONC
$36B
| $9.24M | 1.02% |
70,000
| – | – |
|
25
Evolent Health
EVH
$1B
| $6.92M | 0.76% |
550,000
| – | – |
|